Advagene Biopharma Co Ltd
TPEX:6709
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Advagene Biopharma Co Ltd
TPEX:6709
|
TW |
|
V
|
Vedanta Aluminium Metal Ltd
NSE:VAML
|
IN |
|
R
|
Raytek Semiconductor Inc
TPEX:7873
|
TW |
|
Nanto Bank Ltd
TSE:8367
|
JP |
|
A
|
AAV Group JSC
VN:AAV
|
VN |
|
U
|
United Alloy-Tech Co
TPEX:3162
|
TW |
|
Taisol Electronics Co Ltd
TWSE:3338
|
TW |
|
E
|
Enity Holding AB (publ)
STO:ENITY
|
SE |
|
Rogue Resources Inc
XTSX:TRAN
|
CA |
|
D
|
Dayou AP Co Ltd
KOSDAQ:290120
|
KR |
|
APAQ Technology Co Ltd
TWSE:6449
|
TW |
Bankruptcy Probability
Advagene Biopharma Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Advagene Biopharma Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TW |
A
|
Advagene Biopharma Co Ltd
TPEX:6709
|
1.8B TWD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
628.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
328.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
181.6B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
258.1B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Advagene Biopharma Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Advagene Biopharma Co Ltd has total debt of 2.6m TWD. This includes both short-term (0 TWD) and long-term (2.6m TWD) debt.
You can find a full breakdown on its Balance Sheet.
